Download PDFPDF
Original article
Multidisciplinary home-based rehabilitation in inoperable lung cancer: a randomised controlled trial
  1. Lara Edbrooke1,2,
  2. Sanchia Aranda3,4,
  3. Catherine L Granger1,5,
  4. Christine F McDonald6,7,
  5. Mei Krishnasamy8,9,
  6. Linda Mileshkin10,11,
  7. Ross A Clark12,
  8. Ian Gordon13,
  9. Louis Irving14,
  10. Linda Denehy2,15
  1. 1 Department of Physiotherapy, The University of Melbourne, Parkville, Victoria, Australia
  2. 2 Allied Health Service, The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
  3. 3 Cancer Council Australia, Sydney, New South Wales, Australia
  4. 4 Department of Nursing, The University of Melbourne, Parkville, Victoria, Australia
  5. 5 Department of Physiotherapy, Royal Melbourne Hospital, Parkville, Victoria, Australia
  6. 6 Department of Respiratory and Sleep Medicine, Institute for Breathing and Sleep, Austin Health, Heidelberg, Victoria, Australia
  7. 7 Department of Medicine, The University of Melbourne, Parkville, Victoria, Australia
  8. 8 Department of Nursing and Centre for Cancer Research, The University of Melbourne, Parkville, Victoria, Australia
  9. 9 Victorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia
  10. 10 Department of Medical Oncology, The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
  11. 11 Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia
  12. 12 University of the Sunshine Coast, Sippy Downs, Queensland, Australia
  13. 13 Statistical Consulting Centre, The University of Melbourne, Parkville, Victoria, Australia
  14. 14 Department of Respiratory and Sleep Medicine, Royal Melbourne Hospital, Melbourne, Victoria, Australia
  15. 15 School of Health Sciences, The University of Melbourne, Parkville, Victoria, Australia
  1. Correspondence to Dr Linda Denehy, School of Health Sciences, The University of Melbourne, Parkville, VIC 3010, Australia; l.denehy@unimelb.edu.au

Abstract

Background Lung cancer is associated with poor health-related quality of life (HRQoL) and high symptom burden. This trial aimed to assess the efficacy of home-based rehabilitation versus usual care in inoperable lung cancer.

Methods A parallel-group, assessor-blinded, allocation-concealed, randomised controlled trial. Eligible participants were allocated (1:1) to usual care (UC) plus 8 weeks of aerobic and resistance exercise with behaviour change strategies and symptom support (intervention group (IG)) or UC alone. Assessments occurred at baseline, 9 weeks and 6 months. The primary outcome, change in between-group 6 min walk distance (6MWD), was analysed using intention-to-treat (ITT). Subsequent analyses involved modified ITT (mITT) and included participants with at least one follow-up outcome measure. Secondary outcomes included HRQoL and symptoms.

Results Ninety-two participants were recruited. Characteristics of participants (UC=47, IG=45): mean (SD) age 64 (12) years; men 55%; disease stage n (%) III=35 (38) and IV=48 (52); radical treatment 46%. There were no significant between-group differences for the 6MWD (n=92) at 9 weeks (p=0.308) or 6 months (p=0.979). The mITT analyses of 6MWD between-group differences were again non-significant (mean difference (95% CI): 9 weeks: −25.4 m (−64.0 to 13.3), p=0.198 and 6 months: 41.3 m (−26.7 to 109.4), p=0.232). Significant 6-month differences, favouring the IG, were found for HRQoL (Functional Assessment of Cancer Therapy–Lung: 13.0 (3.9 to 22.1), p=0.005) and symptom severity (MD Anderson Symptom Inventory–Lung Cancer: −2.2 (−3.6 to –0.9), p=0.001).

Conclusions Home-based rehabilitation did not improve functional exercise capacity but there were improvements in patient-reported exploratory secondary outcomes measures observed at 6 months.

Trial registration Australian New Zealand Clinical Trials Registry (ACTRN12614001268639).

  • non-small cell lung cancer
  • exercise

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Presented at This study was presentated at the European Respiratory Society Congress, 2018.

  • Contributors LD, SA, CLG, CFM, MK, LM and LI conceived the study and devised the design. IG devised the statistical analysis plan. LE co-ordinated the trial and was responsible for data acquisition. IG and LE undertook the data analyses and interpretation. LE drafted the manuscript. All authors critically reviewed the manuscript and approved the final version prior to submission. LE managed the manuscript submission.

  • Funding This trial was funded through a National Health and Medical Research project grant (APP1060484). LE is the recipient of a Victorian Government Olivia Newton John Cancer Wellness and Research Centre Supportive Care PhD scholarship, through the Victorian Cancer Agency.

  • Disclaimer The funders of the trial had no role in trial design, data collection, data analysis, data interpretation or writing of the report.

  • Competing interests None declared.

  • Patient consent for publication Obtained.

  • Ethics approval The Peter MacCallum Cancer Centre Human Research Ethics Committee (HREC/14/PMCC/27).

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement Data are available upon reasonable request.

Linked Articles